| |
Benign
(n=27) |
Borderline
(n=25) |
Malignant
(n=33) |
pValue |
| Age in years |
| (Range) |
16-54 |
19-55 |
19-69 |
p = 0.585 |
| (Mean) |
36 ± 12 |
37.6 ± 9.8 |
38.7 ± 13.2 |
| (Median) |
35 |
38 |
38 |
| Age groups |
|
• 30 years or below
|
10 (37%) |
05 (20%) |
10 (30.3%) |
p = 0.633 |
|
• 31 to 50 years
|
15 (55.6%) |
17 (68%) |
18 (54.4%) |
|
• 51 years or above
|
02 (7.4%) |
03 (12%) |
05 (15.2%) |
| Tumor size (cm) |
| (Range) |
2-18 |
2.2-19 |
2.7-23 |
P <0.0001 |
| (Mean) |
5.2 ± 3.3 |
9.1 ± 4.7 |
10.6 ± 5.3 |
| (Median) |
4.5 |
8.5 |
9 |
| Tumor size (groups) |
|
• Below 5 cm
|
19 (70.4%) |
04 (16%) |
06 (18.2%) |
p< 0.0001 |
|
• 5 to 10 cm
|
06 (22.2%) |
12 (48%) |
12 (36.4%) |
|
• Above 10 cm
|
02 (7.4%) |
09 (36%) |
15 (45.5%) |
| CD 10 staining (score) |
|
• 0 (no staining)
|
04 (14.8%) |
03 (12%) |
02 (6.1%) |
p< 0.0001 |
|
• 1+ (weak)
|
19 (70.4%) |
06 (24%) |
05 (15.2%) |
|
• 2+ (moderate)
|
02 (7.4%) |
10 (40%) |
12 (36.4%) |
|
• 3+ (strong)
|
02 (7.4%) |
06 (24%) |
14 (42.4%) |
| Significant CD10 staining* |
|
• CD10 Positive
|
05 (18.5%) |
16 (64%) |
26 (78.8%) |
p< 0.0001 |
|
• CD10 Negative
|
22 (81.5%) |
09 (36%) |
07 (21.2%) |
| Skin ulceration |
00 |
02 (8%) |
03 (9.1%) |
p = 0.286 |
|
| *Based upon CD10 staining scores, the cases were termed CD10 positive and CD10 negative. Cases with score of 0 and 1+ were considered negative while cases with score of 2+ and 3+ were considered positive. |
| Table 2: Comparison of clinicopathological features in categories of phylloides tumor. |
